Targeting USP1-dependent KDM4A protein stability as a potential prostate cancer therapy

Authors

Shu-Zhong Cui, Affiliated Cancer Hospital and Institute of Guangzhou Medical University
Zi-Ying Lei, Affiliated Cancer Hospital and Institute of Guangzhou Medical University
Tian-Pei Guan, Affiliated Cancer Hospital and Institute of Guangzhou Medical University
Ling-Ling Fan, University of Maryland at Baltimore
You-Qiang Li, University of Maryland at Baltimore
Xin-Yan Geng, University of Maryland at Baltimore
De-Xue Fu, University of Maryland at Baltimore
Hao-Wu Jiang, Washington University School of Medicine in St. Louis
Song-Hui Xu, University of Maryland at Baltimore

Journal

Cancer science

Publication Date

5-1-2020

Volume

111

Issue

5

First Page

1567

Last Page

1581

Document Type

Open Access Publication

DOI

10.1111/cas.14375

Rights and Permissions

Cui, S-Z, Lei, Z-Y, Guan, T-P, et al. Targeting USP1-dependent KDM4A protein stability as a potential prostate cancer therapy. Cancer Sci. 2020; 111: 1567– 1581. doi.org/10.1111/cas.14375 © 2020 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

Recommended Citation

Cui, Shu-Zhong; Lei, Zi-Ying; Guan, Tian-Pei; Fan, Ling-Ling; Li, You-Qiang; Geng, Xin-Yan; Fu, De-Xue; Jiang, Hao-Wu; and Xu, Song-Hui, "Targeting USP1-dependent KDM4A protein stability as a potential prostate cancer therapy." Cancer science. 111, 5. 1567 - 1581. (2020).
https://digitalcommons.wustl.edu/open_access_pubs/11803